FDA.reportPublic FDA data

Application 062298

Type
ANDA
Sponsor
ARBOR PHARMS LLC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ERY-TABERYTHROMYCINTABLET, DELAYED RELEASE;ORAL250MGNoNo
002ERY-TABERYTHROMYCINTABLET, DELAYED RELEASE;ORAL500MGNoYes
003ERY-TABERYTHROMYCINTABLET, DELAYED RELEASE;ORAL333MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
24338-122ERY-TABErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
24338-124ERY-TABErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
24338-126ERY-TABErythromycinArbor Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
43063-569ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
50090-0339ERY-TABErythromycinA-S Medication SolutionsANDACurrent
50090-0339ERY-TABErythromycinA-S Medication SolutionsANDACurrent
52536-180ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
52536-183ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
52536-186ErythromycinErythromycinWilshire PharmaceuticalsANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, InANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-217ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, InANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
55289-525ERY-TABErythromycinPD-Rx Pharmaceuticals, Inc.ANDACurrent
68151-1170ERY-TABErythromycinCarilion Materials ManagementANDACurrent
68151-1174ERY-TABErythromycinCarilion Materials ManagementANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
39397SUPPL2014-01-31